37 related articles for article (PubMed ID: 8589362)
1. Mutational Profiles of
Zahari M; Sulaiman SA; Othman Z; Ayob Y; Karim FA; Jamal R
Mediterr J Hematol Infect Dis; 2018; 10(1):e2018056. PubMed ID: 30210749
[TBL] [Abstract][Full Text] [Related]
2. Alloantibodies in von Willebrand disease.
James PD; Lillicrap D; Mannucci PM
Blood; 2013 Aug; 122(5):636-40. PubMed ID: 23297130
[TBL] [Abstract][Full Text] [Related]
3. [The occurrence of immunological tolerance to inhibitors of factors VIII and IX in hemophilia patients].
Brakman GG
Gematol Transfuziol; 1993 Feb; 38(2):18-20. PubMed ID: 8020714
[TBL] [Abstract][Full Text] [Related]
4. [A retrospective study on the development of inhibitors in Japanese hemophiliacs (second report, 1994 study). Research Group of Blood Products for Hemophilia Inhibitor].
Kamiya T; Nagao T; Yoshioka A
Rinsho Ketsueki; 1998 May; 39(5):402-4. PubMed ID: 9637893
[TBL] [Abstract][Full Text] [Related]
5. [Prospective matched control study concerning the treatment and quality of life of hemophiliacs with inhibitors].
Honda K; Nagao T; Kamiya T; Yoshioka A; Miyazaki T; Takeda T; Mori K; Fukutake K; Hanabusa H; Taki M; Mohri H; Miyama J; Takamatsu J; Kinoshita S; Shirahata A
Rinsho Ketsueki; 1998 Jun; 39(6):416-21. PubMed ID: 9695668
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of inhibitors in hemophiliacs with reference to the transfusion of blood products (author's transl)].
Kamiya T
Rinsho Byori; 1978; 26(4):291-7. PubMed ID: 671775
[No Abstract] [Full Text] [Related]
7. [Hemophiliacs with inhibitor. Experience at the Center of Medical Action for Hemophilia of the S. José Hospital].
Diniz MJ; Dias Francisco F; Tavares ML; Leal I
Acta Med Port; 1992 Apr; 5(4):178-80. PubMed ID: 1605065
[TBL] [Abstract][Full Text] [Related]
8. Retrospective study of inhibitor formation in Japanese hemophiliacs.
Kamiya T; Takahashi I; Saito H
Int J Hematol; 1995 Oct; 62(3):175-81. PubMed ID: 8589362
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor antibodies to factor VIII and factor IX: management.
Lusher JM
Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
[TBL] [Abstract][Full Text] [Related]
10. The role of genetics in inhibitor formation.
Gill JC
Thromb Haemost; 1999 Aug; 82(2):500-4. PubMed ID: 10605742
[TBL] [Abstract][Full Text] [Related]
11. [Risk of the appearance of inhibitors linked to the administration of factors VIII and IX. Review of the literature].
Calvez T; Costagliola D
Transfus Clin Biol; 1994; 1(6):427-35. PubMed ID: 7881588
[TBL] [Abstract][Full Text] [Related]
12. Overview of inhibitors.
Astermark J
Semin Hematol; 2006 Apr; 43(2 Suppl 4):S3-7. PubMed ID: 16690373
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
